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Introduction
Spinocerebellar ataxia 7 (SCA7) is a rare form of autosomal dominant cerebellar ataxia (ADCA). 1 Patients suffer from unremitting cerebellar ataxia associated with progressive macular dystrophy. [2] [3] [4] [5] The molecular defect involved in this disease has been identified as the abnormal expansion of a (CAG) n repeat in the coding region of the SCA7 gene on chromosome 3. [6] [7] [8] The same type of mutation has been implicated in other neurogenerative disorders such as Huntington's disease, spinobulbar muscular atrophy, dentatorubro-pallidoluysian atrophy, as well as in other genetic subtypes of ADCA: SCA1, SCA2, SCA3/MJD (Machado-Joseph disease) and SCA6.
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SCA7 is a minor mutation that accounts for 5 to 12% of ADCA, 8, 10, 11 but is found in a wide variety of countries and in patients of many ethnic origins. 7, [12] [13] [14] [15] [16] [17] [18] We describe here a new intragenic polymorphism of the SCA7 gene (G 
Materials and Methods
Patients and Families
Non-SCA1,2,3 and six patients with autosomal dominant cerebellar ataxia and sporadic cases were screened for the SCA7 mutation. Thirty-nine unrelated families and two isolated patients 19, 20 were identified representing about 6% of ADCA and less than 1% of isolated ataxias. 11 Twenty of these cases, five of which were recruited in the USA, were European Caucasians (six were from France, 10 from the UK, two from Italy and one each from Belgium and Germany). Thirteen kindreds were non-black North Africans (seven from Morocco, five from Algeria and one from Tunisia). Four families were Asian (three from Korea and one from the Philippines). A kindred, of Jewish ancestry, originated from the Arabian peninsula. One each were from Jamaica, Brazil and South Africa but their ethnic background could not be precisely determined. The clinical and genetic profiles of 38 of these kindreds, including partial haplotypes in 16, have been previously reported. 12, 15, 16, [19] [20] [21] 
Intragenic Polymorphism
The SCA7 cDNAs clones D1 and A10, 6 obtained from different cDNA libraries generated from two lymphoblastoid cell lines of ataxic patients, 22 
Microsatellite Markers and Genotyping
Genotypes were determined for six microsatellite markers spanning about 8 cM on chromosome 3p:
. SCA7 is distal to D3S1287 and proximal to D3S1600. 7 Each marker was amplified by PCR and genotypes were determined using allele numbering as described. 12, 21 Allele frequencies were determined from at least 63 control individuals mostly of European or North African origin. 
Linkage Disequilibrium Analysis
Allele distribution on normal and carrier chromosomes was compared at each locus by the two-tailed Fisher's exact test, and the Yates corrected 2 test when necessary. Only the ancestral disease-linked allele or haplotype of each family was used if it could be determined. The frequency of each allele was compared with a pool of all the others treated as a second allele. The presence of linkage disequilibrium was tested with the formula D st = √ ( 2 /N) using the uncorrected 2 value. 23 Comparison of means was performed using the non-parametric Mann Whitney-U test.
Results
Analysis of the G 3145 TG/A 3145 TG Intragenic Polymorphism
The frequencies of alleles A and B of the polymorphism, determined by PCR and NlaIII digestion on 69 healthy unrelated individuals, were 31 and 69%, respectively ( Table 1 ). The observed heterozygosity rate was 35% in the whole population. This was lower, although not significantly, than the expected 43% heterozygosity given the allele frequencies. The relative proportions of each allele in European and North African populations differed significantly (P < 0.05, Table 1 ).
The allele of the intragenic polymorphism segregating with the SCA7 mutation was determined in 34 of 41 families and the presence of linkage disequilibrium (LD) between the polymorphism and the CAG repeat expansion was examined. Allele A segregated with the disease in 27/34 of the SCA7 kindreds and was significantly more frequent in patients than in controls, in the whole sample (P < 0.001) and in the North African and European populations (P < 0.05, Table 2 ). Allele A was in complete linkage disequilibrium with the mutations in North Africa and also segregated with the mutation in the four Asian kindreds (Table 3 ). In On normal chromosomes, allele A was associated with a significantly (P < 0.001) larger number of CAG repeats (11.0 ± 1.4 CAG repeats, from 7 to 13, n = 39) than allele B (10.0 ± 0.4 repeats, from 9 to 12, n = 57), a feature that remained significant when European and North African populations were analysed separately. Alleles carrying 10 CAG repeats represented 46% of those associated with polymorphism A and 95% of those with polymorphism B. In European controls, all the alleles with polymorphism B were associated with 10 CAG repeats.
We found no relationships between the allele carried by the patients and their clinical presentation (age at onset, disease severity) or degree of intergenerational instability.
To establish the position of the G 3145 TG/A 3145 TG polymorphism with respect to the (CAG) n repeat sequence and flanking microsatellite markers, we screened the subset of YACs which constitutes a contig of the SCA7 region by PCR. 12 The SCA7 (CAG)n repeat is located between D3S1600 and the G 3145 TG/A 3145 TG polymorphism * Families in which IA segregate or are at the origin of de novo expansion.
18
Linkage disequilibrium at the SCA7 locus t G Stevanin et al-cen. Since fewer YACs carry D3S1600 rather than D3S1287, the latter is probably closer to the SCA7 gene.
Linkage Disequilibrium with Flanking Microsatellite Markers
The SCA7 mutation was in significant linkage disequilibrium (LD) with two of the centromeric markers (Table 2 ). Allele 6 of D3S3635 was significantly more frequent in patients of all origins than in controls (P < 0.05). Although allele 6 was frequently found in European (53%) and North African (47%) controls, LD was significant in both groups (P < 0.05). Allele 6 of marker D3S3644 segregated more frequently in patients than in controls in the whole SCA7 population (P < 0.05), but its frequency did not differ significantly in each population independently.
We found no LD with the closely flanking loci. Allele 3 of marker D3S1287 segregated with the disease in 18/31 kindreds, but this allele was frequently detected in controls (P > 0.05). In North Africans, allele 3 of this marker segregated in 10/11 SCA7 families but it represented 79% of the normal chromosomes (P > 0.05). Finally, 7 different alleles of marker D3S1600 were found in SCA7 patients, but none were in significant LD (P > 0.05) with the SCA7 mutation. This would be consistent with a distance between the marker and the expansion that is greater for D3S1600 than D3S1287, as suggested by the results of the YAC screening (see above).
Disease-linked Haplotypes
Complete or partial SCA7-carrier haplotypes could be reconstructed in 33/41 SCA7 kindreds (Table 3) . Seventeen D3S1600-G 3145 TG/A 3145 TG-D3S1287-D3S3635 haplotypes were observed in the SCA7 families. Families grouped according to their origin shared common haplotypes, particularly in the centromeric part of the SCA7 region. Four major haplotypes of the centromeric markers (G 3145 TG/A 3145 TG-D3S1287-D3S3635) accounted for 75% (21/28) of those associated with the disease and were found, with few exceptions, in four different geographic areas: A-2-4 in Korea, A-3-6 in North Africa, B-3-6 in continental Europe (France and Belgium) and A-4-6 in the UK and USA. The major haplotype (A-3-6) was more frequently observed in the SCA7 kindreds than in controls (P < 0.01), particularly in those of North African descent (P < 0.001), as shown by the D st value of 0.70 (Table 2) . In European kindreds, haplotype B-3-6 occurred more frequently in continental families (P < 0.05) whereas haplotype A-4-6 was observed in kindreds from the UK and North America. Given the small number of families, the difference between normal and carriers chromosomes did not reach statistical significance for the other haplotypes.
The telomeric portion of the chromosome was less conserved among the families, even those of common origin, in this study as well as in four previously published Swedish kindreds.
14 This could be explained by the position of the mutation that is probably closer to D3S1287 than to D3S1600. The haplotypes segregating in the German, Brazilian, Jamaican and Filipino pedigrees were different, suggesting independent ancestral mutations. In the Jamaican pedigree, the linked haplotype also diverged with respect to the number of (CCG) n repeats present immediately 3' to the (CAG) n repeat. 6 Three repeats were present instead of the two usually found. 20 This variation was observed by direct sequencing with primers 4U-1024 and 4U-716 6 only in this kindred and on one control chromosome, but not on 10 normal, two intermediatesized or two pathological alleles (data not shown).
Interestingly, the linked haplotypes segregating in the two Italian families diverged both in their telomeric and centromeric regions surrounding the intragenic marker, except for allele 3 at D3S1287, which is frequent.
Discussion
We have described a new intragenic polymorphism (G
3145
TG/A 3145 TG) that is in linkage disequilibrium with the SCA7 mutation. Allele A predominates in Anglo-Saxon (UK and USA), Asian and North African kindreds, allele B in continental European families. We found that almost all alleles B, but only 50% of alleles A, are associated with chromosomes carrying 10 CAG repeats in controls. This suggests that allele B derived from an allele A carrying 10 repeat units. Alternatively, allele A might be associated with chromosomes that are more prone to instability and might explain why allele B is rare on pathological chromosomes. However, although allele A segregated in 79% of the SCA7 families, it was not correlated with a greater degree of instability in the SCA7 patients studied.
Multiple Origins of the SCA7 Mutation?
The intragenic polymorphism distinguishes haplotypes associated with the mutation in continental European from those in North African families. Four major TG -D3S1287 and D3S3635 were found in most families. This argues in favour of multiple origins for the SCA7 mutation. The existence of different haplotypes in single families from Germany, the Arabian peninsula, South Africa, Brazil, Jamaica and the Philippines, and of different haplotypes in families originating from the same area (ie the two Italian families), also argues in favour of multiple origins. In Europe, three different haplotypes A-4-6, B-3-6 and A-3-6 possibly reflect three different founders.
Haplotypes are Shared by Families from Common Geographic Areas
Partial haplotypes were conserved among families with common geographic origins (North Africa, Korea, continental Europe and Anglo-Saxon countries). This could result from regional founder effects or from recurrent mutations on at-risk haplotypes, which differ according to geographic area. Regional founder effects appear to be common in spinocerebellar ataxias and were previously shown for SCA1, 24 SCA2, 25, 26 SCA3/ MJD [27] [28] [29] [30] [31] [32] and SCA6. 33 The observation that haplotypes were less conserved among families from continental Europe and AngloSaxon countries than from North Africa might be explained by more ancient founder mutations which would be associated with more recombination events, microsatellite mutations or single-base pair changes. The observation that haplotypes were less conserved for telomeric markers that are more distant from the SCA7 locus is consistent with recombination events following the ancestral mutation, in particular if there was a hot spot of recombination in this region. David et al 12 demonstrated a marked discrepancy between physical and genetic distances in the SCA7 region, suggesting that this might be the case. The Tunisian haplotype which is identical to that of other North African pedigrees, except for the addition of a single CA repeat at D3S1287, is probably an example of a microsatellite mutation on a conserved haplotype. Similarly, the haplotype segregating in Korean and Filipino kindreds differed by a single CA repeat at D3S1287.
Relation between IA and SCA7-linked Haplotypes
The SCA7 expansion is much more unstable during transmission between generations than other SCA loci (mean increase of + 12 CAG rather than + 1 or + 2). 1 This instability, which results in anticipation of about 20 years, should have led to rapid extinction of this disorder. This has not been the case, however, because of some instability of large normal alleles or intermediate alleles (IA), particularly during paternal transmissions, that leads to de novo expansion. 20 In Huntington's disease, de novo mutations that also occur on intermediate-sized alleles, were associated with the most common haplotype linked to the disease. 34, 35 In the spinocerebellar ataxias, the frequencies of the mutations are closely related to those of IA in different ethnic groups. 36 Furthermore, large normal alleles and disease-linked chromosomes in SCA3 and DRPLA share similar haplotypes. 31, 37 Do IAs share haplotypes with the SCA7 mutations?
In SCA7, intermediate alleles, observed in three different populations, even in individuals of common origin (ie the Italian families) do not have the same haplotype. Different pools of IA that can give rise to the disease therefore exist. IAs were observed in Tunisia with the same haplotype as the SCA7 mutation in a family from the same region 20 and also resemble those found in the majority of North African SCA7 kindreds. In this Tunisian pedigree, an IA segregated in one branch of the kindred, whereas expansions were transmitted in other branches. 20 In two Swedish SCA7 kindreds related to a single founder, 14 the disease appeared independently, associated with similar haplotypes, five and eight generations later, probably by expansion of an IA transmitted by a common ancestor.
These data suggest that recurrent de novo expansions on at-risk haplotypes, derived from a founder chromosome which carries an IA, can account for the shared haplotypes observed in families from the same geographic area. De novo expansion on founder chromosomes has been demonstrated in the majority of the fragile X families of Finnish and Tunisian Jewish origins. 38, 39 More than one pool of at-risk chromosomes may be present in a single population, however, as illustrated by the two Italian families in the present study where IA giving rise to de novo mutations had different haplotypes.
